Umami Bioworks Marine Cell Cultivation Delivers PDRN Without Reliance on Salmon Sperm Harvesting

Umami Bioworks, a biotechnology company based in Singapore, has introduced a new platform called Marine Radiance for developing marine-derived bioactives. They have announced the world's first animal-free polydeoxyribonucleotide (PDRN) for use in skincare and medical applications. Currently, PDRN is sourced from salmon sperm, which involves logistical, ethical, and biosecurity concerns.

Umami Bioworks' new PDRN is produced using cultivated marine cell lines grown in controlled environments. This approach eliminates the need for animal harvesting, while allowing for scalable and localized production. The company's ALKEMYST platform uses AI-assisted cell cultivation to develop marine ingredients for various industries, including cosmetics, supplements, food, and pharmaceuticals. They are already working with partners in skincare and regenerative health industries to develop new PDRN-based formulations, providing a scalable and sustainable source of bioactives.